High prevalence of autoantibodies to C-reactive protein in patients with chronic hepatitis C infection: association with liver fibrosis and portal inflammation-Reference-Cited by-同舟云学术

High prevalence of autoantibodies to C-reactive protein in patients with chronic hepatitis C infection: association with liver fibrosis and portal inflammation

Published:2012-04 Issue:4 Volume:73 Page:382-388
ISSN:0198-8859
Container-title:Human Immunology
language:en
Short-container-title:Human Immunology

Author:

Sjöwall Christopher,Cardell Kristina,Boström Elisabeth A.,Bokarewa Maria I.,Enocsson Helena,Ekstedt Mattias,Lindvall Liselott,Frydén Aril,Almer Sven

Publisher

Elsevier BV

Subject

General Medicine,Immunology,Immunology and Allergy

Reference47 articles.

1. Clinical practice;Rosen;N Engl J Med,2011

2. Chronic HCV-related autoimmunity: a consequence of viral persistence and lymphotropism;Kessel;Curr Med Chem,2007

3. Treatment of chronic hepatitis C infection: one step at a time;Davis;Lancet Infect Dis,2005

4. Excess mortality rates in a cohort of patients infected with the hepatitis C virus: a prospective study;Neal;Gut,2007

5. Liver cirrhosis;Schuppan;Lancet,2008

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sex-specific differences in the effect of lymphocyte-to-C-reactive protein ratio on subclinical myocardial injury in the general population free from cardiovascular disease;Nutrition, Metabolism and Cardiovascular Diseases;2023-12

2. C-Reactive Protein: Pathophysiology, Diagnosis, False Test Results and a Novel Diagnostic Algorithm for Clinicians;Diseases;2023-09-28

3. The relationship between C-reactive protein to lymphocyte ratio and the prevalence of myocardial infarction in US adults: A cross-sectional study;Heliyon;2023-07

4. Biosensor development for C-reactive protein detection: A review;Applied Surface Science Advances;2022-12

5. High C-Reactive Protein-to-Lymphocyte Ratio Is Predictive of Unfavorable Prognosis in HBV-Associated Decompensated Cirrhosis;Laboratory Medicine;2022-04-04